Detection of capsular polysaccharide in serum for the diagnosis of pneumococcal pneumonia: Clinical and experimental evaluation

22Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

To improve diagnostic options for pneumococcal pneumonia, an ELISA system was developed that can detect <6 ng/ml capsular polysaccharide in serum. The test was limited to 39 serotypes causing >95% of pneumococcal infections. In clinical evaluation the test identified 14 of 15 cases (missing one serotype not included). No false-positive reaction occurred. However, the duration and level of antigenemia were variable (>500-2.5 ng/ml) and seemed not to depend solely on the severity of infection. Therefore, the question of whether the extent of antigenemia was determined by a serotype-dependent variation in the elimination rates of polysaccharides was investigated. Clearance rates for 12 serotypes varied in rabbits and rats by a factor of >250. This remarkable variability appeared to affect the extent of clinical antigenemia. Thus, only very sensitive systems can detect circulating antigen from rapidly cleared polysaccharide serotypes. Furthermore, the question arises whether slow polysaccharide clearance contributes to the virulence of some pneumococcal serotypes. © 1991 by The University of Chicago.

Cite

CITATION STYLE

APA

Schaffner, A., Michel-Harder, C., & Yeginsoy, S. (1991). Detection of capsular polysaccharide in serum for the diagnosis of pneumococcal pneumonia: Clinical and experimental evaluation. Journal of Infectious Diseases, 163(5), 1094–1102. https://doi.org/10.1093/infdis/163.5.1094

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free